FILING ANALYSIS · THURSDAY, NOVEMBER 5
Evolent Health, Inc. EVH — 8-K: Results of Operations and Financial Condition
neutral
Evolent Health reported a revenue increase of 51% year-over-year to $725.4 million, with a net loss of $23.6 million, and adjusted EBITDA of $34.3 million, but the medical expense ratio rose to 93.0% from 85.0% in the prior year, which may be a concern for investors. The company also announced new and renewed contracts, including a four-year renewal with its largest Surgical Management customer an
How we read impact: we grade every directional call in the open. Impact labels are AI estimates — not investment advice. See the full disclaimer.
Get filings like this every market day
The US SEC filings, UK RNS, EU notices, and Polymarket odds that matter — scored by AI, in one email.
Subscribe free →